Macrophages are involved in the protective role of human umbilical cord-derived stromal cells in renal ischemia-reperfusion injury

Stem Cell Research

Volumn 10, Issue 3, 2013, Pages 405-416

  Li, Wei ^a,c   Zhang, Qiang ^a   Wang, Mei ^a   Wu, Huiyi ^c   Mao, Fei ^a   Zhang, Bin ^a   Ji, Runbi ^a   Gao, Shuo ^a   Sun, Zixuan ^a   Zhu, Wei ^a   Qian, Hui ^a   Chen, Yongchang ^a   Xu, Wenrong ^a,b  

^a JIANGSU UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^c First People's Hospital of Lianyungang   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD DERIVED STROMAL CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY FUNCTION; KIDNEY ISCHEMIA; LOWER TUBULAR INJURY SCORE; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; STROMA CELL; UMBILICAL CORD;

ANIMALS; CELL LINE; CELL PROLIFERATION; CELL TRACKING; COCULTURE TECHNIQUES; CYTOKINES; HUMANS; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; PHENOTYPE; REPERFUSION INJURY; STROMAL CELLS; UMBILICAL CORD;

EID: 84874736577     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.01.005     Document Type: Article

References (30)

1. Aronin C.E.P., Tuan R.S. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res. 2010, 90:67-74.
2. Bonventre J.V., Yang L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 2011, 121:4210-4221.
3. Cao H., Qian H., Xu W., Zhu W., Zhang X., Chen Y., Wang M., Yan Y., Xie Y. Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnol. Lett. 2010, 32:725-732.
4. Chao K.C., Chao K.F., Fu Y.S., Liu S.H. Islet-like clusters derived from mesenchymal stem cells in Wharton's jelly of the human umbilical cord for transplantation to control type 1 diabetes. PLoS One 2008, 1:e1451.
5. Chen L., Tredget E.E., Wu P.Y.G., Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008, 3:e1886.
6. Chen Y., Qian H., Zhu W., Zhang X., Yan Y., Ye S., Peng X., Li W., Xu W. Hepatocyte growth factor modification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury. Stem Cells Dev. 2011, 20:103-113.
7. Choi Y.S., Jeong J.A., Lim D.S. Mesenchymal stem cell-mediated immature dendritic cells induce regulatory T cell-based immunosuppressive effect. Immunol. Invest. 2012, 41:214-229.
8. Day Y.J., Huang L., Ye H., Linden J., Okusa M.D. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am. J. Physiol. Renal Physiol. 2005, 288:F722-F731.
9. Dayan V., Yannarelli G., Billia F., Filomeno P., Wang X.H., Davies J.E., Keating A. Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction. Basic Res. Cardiol. 2011, 106:1299-1310.
10. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 2005, 115:56-65.
11. Feng Z., Ting J., Alfonso Z., Strem B.M., Fraser J.K., Rutenberg J., Kuo H.C., Pinkernell K. Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury. Nephrol. Dial. Transplant. 2010, 25:3874-3884.
12. Jang H.R., Ko G.J., Wasowska B.A., Rabb H. The interaction between ischemia-reperfusion and immune responses in the kidney. J. Mol. Med. 2009, 87:859-864.
13. Jo S.K., Sung S.A., Cho W.Y., Go K.J., Kim H.K. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol. Dial. Transplant. 2006, 21:1231-1239.
14. Kennedy S.E., Erlich J.H. Murine renal ischaemia-reperfusion injury. Nephrology 2008, 13:390-396.
15. Kim J., Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp. Hematol. 2009, 37:1445-1453.
16. Maggini J., Mirkin G., Bognanni I., Holmberg J., Piazzón I.M., Nepomnaschy I., Costa H., Cañones C., Raiden S., Vermeulen M., Geffner J.R. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010, 5:e9252.
17. Morigi M., Introna M., Imberti B., Corna D., Abbate M., Rota C., Rottoli D., Benigni A., Perico N., Zoja C., Rambaldi A., Remuzzi A., Remuzzi G. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008, 26:2075-2082.
18. Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 2007, 110:3499-3506.
19. Németh K., Leelahavanichkul A., Yuen P.S.T., Mayer B., Parmelee A., Doi K., Robey P.G., Leelahavanichkul K., Koller B.H., Brown J.M., Hu X., Jelinek I., Star R.A., Mezey É. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 2009, 15:42-49.
20. Panepucci R.A., Siufi J.L.C., Silva W.A., Proto-Siquiera R., Neder L., Orellana M., Rocha V., Covas D.T., Zago M.A. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004, 22:1263-1278.
21. Qian H., Yang H., Xu W., Yan Y., Chen Q., Zhu W., Cao H., Yin Q., Zhou H., Mao F., Chen Y. Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int. J. Mol. Med. 2008, 22:325-332.
22. Qiao C., Xu W., Zhu W., Hu J., Qian H., Yin Q., Jiang R., Yan Y., Mao F., Yang H., Wang X., Chen Y. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol. Int. 2008, 32:8-15.
23. Ricardo S.D., Goor H.V., Eddy A.A. Macrophage diversity in renal injury and repair. J. Clin. Invest. 2008, 118:3522-3530.
24. Rooijen N.V., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 1994, 174:83-93.
25. Semedo P., Palasio C.G., Oliveira C.D., Feitoza C.Q., Gonçalves G.M., Cenedeze M.A., Wang P.M.H., Teixeira V.P.A., Reis M.A., Pacheco-Silva A., Câmara N.O.S. Early modulation of inflammation by mesenchymal stem cell after acute kidney injury. Int. Immunopharmacol. 2009, 9:677-682.
26. Sica A., Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 2012, 122:787-795.
27. Tögel F., Hu Z., Weiss K., Isaac J., Lange C., Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 2005, 289:F31-F42.
28. Tsuda H., Yamahara K., Ishikane S., Otani K., Nakamura A., Sawai K., Ichimaru N., Sada M., Taguchi A., Hosoda H., Tsuji M., Kawachi H., Horio M., Isaka Y., Kangawa K., Takahara S., Ikeda T. Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. Am. J. Physiol. Renal Physiol. 2010, 299:F1004-F1013.
29. Vinuesa E., Hotter G., Jung M., Herrero-Fresneda I., Torras J., Sola A. Macrophage involvement in the kidney repair phase after ischaemia/reperfusion injury. J. Pathol. 2008, 214:104-113.
30. Zhang Q.Z., Su W.R., Shi S.H., Wilder-Smith P., Xiang A.P., Wong A., Nguyen A.L., Kwon C.W., Le A.D. Human gingiva-derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing. Stem Cells 2010, 28:1856-1868.